US Patent Issued to Northwestern University on Nov. 3 for "KEAP1/NRF2 protein-like polymers" (Illinois Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,012, issued on Nov. 3, was assigned to Northwestern University (Evanston, Ill.). "KEAP1/NRF2 protein-like polymers" was invented by Nathan C... Read More

US Patent Issued to Rutgers, The State University of New Jersey on Nov. 3 for "Modified kisspeptin receptor agonists for fatty liver disease" (New Jersey Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,013, issued on Nov. 3, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.). "Modified kisspeptin receptor agon... Read More

US Patent Issued to BIOXODES on Nov. 3 for "Anticoagulant proteins and their use for treating diseases associated with the activation of neutrophils" (Belgian Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,014, issued on Nov. 3, was assigned to BIOXODES (Marche-en-Famenne, Belgium). "Anticoagulant proteins and their use for treating diseases as... Read More

US Patent Issued to Claris Biotherapeutics on Nov. 3 for "Compositions of growth factor for the treatment of eye disease" (New Jersey Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,015, issued on Nov. 3, was assigned to Claris Biotherapeutics Inc. (Jersey City, N.J.). "Compositions of growth factor for the treatment of ... Read More

US Patent Issued to IP2IPO Innovations on Nov. 3 for "Appetite suppressing compounds" (British Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,016, issued on Nov. 3, was assigned to IP2IPO Innovations Ltd. (London). "Appetite suppressing compounds" was invented by Stephen Robert Blo... Read More

US Patent Issued to CHENGDU AODA BIOTECHNOLOGY on Nov. 3 for "Exenatide analog" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,017, issued on Nov. 3, was assigned to CHENGDU AODA BIOTECHNOLOGY Co. LTD (Chengdu, China). "Exenatide analog" was invented by Shuliang Zhou... Read More

US Patent Issued to HANMI PHARM. on Nov. 3 for "Pharmaceutical composition for preventing or treating bone diseases, comprising triple agonist or conjugate thereof having activity with respect to all of glucagon, GLP-1 and GLP receptors" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,018, issued on Nov. 3, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea). "Pharmaceutical composition for preventing or treat... Read More

US Patent Issued to SNIPR BIOME on Nov. 3 for "Treating and preventing E coli infections" (Danish Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,019, issued on Nov. 3, was assigned to SNIPR BIOME APS (Copenhagen O, Denmark). "Treating and preventing E coli infections" was invented by ... Read More

US Patent Issued to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) on Nov. 3 for "Stabilized Ace2 variant, Ace2-fc fusion protein using same, and method for preventing or treating COVID-19" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,020, issued on Nov. 3, was assigned to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (Seoul, South Korea). "Stabi... Read More

US Patent Issued to Fortvita Biologics (Singapore) on Nov. 3 for "Interleukin-2 mutant and fusion protein thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,021, issued on Nov. 3, was assigned to Fortvita Biologics (Singapore) Pte. Ltd. (Singapore). "Interleukin-2 mutant and fusion protein thereo... Read More

• ««
• «
• 2983
• 2984
• 2985
• 2986
• 2987
• 2988
• 2989
• 2990
• 2991
• 2992
• »
• »»